Technical Analysis for GOVX - GeoVax Labs, Inc.

Grade Last Price % Change Price Change
F 1.85 0.54% 0.01
GOVX closed up 0.54 percent on Wednesday, March 27, 2024, on 30 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 0.54%
Stochastic Reached Oversold Weakness 0.54%
Inside Day Range Contraction 0.54%
Wide Bands Range Expansion 0.54%
Oversold Stochastic Weakness 0.54%
Wide Bands Range Expansion -2.63%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance about 15 hours ago
Fell Below Previous Day's Low about 15 hours ago
Down 1% about 15 hours ago
New 52 Week Low about 15 hours ago
Up 3% about 19 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

GeoVax Labs, Inc. Description

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; the HIV Vaccines Trial Network; Centers for Disease Control and Prevention; U.S. Army Research Institute of Infectious Disease; U.S. Naval Research Laboratory; Emory University; University of Pittsburgh; Georgia State University Research Foundation; University of Texas Medical Branch; the Institute of Human Virology at the University of Maryland; the Scripps Research Institute; the Burnet Institute; American Gene Technologies, Inc.; Viamune, Inc.; Vaxeal Holding SA; CaroGen Corporation; Virometix AG; U.S. Department of Defense; Geneva Foundation; Enesi Pharma; and Leidos, Inc. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Clinical Medicine Infectious Diseases Immunotherapies Vaccines Allergy Hepatitis B Department Of Defense Viruses HIV Immunodeficiency Virus Malaria U.S. Department Of Defense Fever Virology Ebola Zika Chronic Hepatitis Scripps Vaccinia

Is GOVX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.823
52 Week Low 1.82
Average Volume 45,512
200-Day Moving Average 6.41
50-Day Moving Average 2.72
20-Day Moving Average 2.07
10-Day Moving Average 1.92
Average True Range 0.20
RSI (14) 32.43
ADX 30.91
+DI 14.53
-DI 24.22
Chandelier Exit (Long, 3 ATRs) 2.24
Chandelier Exit (Short, 3 ATRs) 2.42
Upper Bollinger Bands 2.48
Lower Bollinger Band 1.67
Percent B (%b) 0.23
BandWidth 39.33
MACD Line -0.25
MACD Signal Line -0.29
MACD Histogram 0.038
Fundamentals Value
Market Cap 3.66 Million
Num Shares 1.98 Million
EPS -13.35
Price-to-Earnings (P/E) Ratio -0.14
Price-to-Sales 59.01
Price-to-Book 0.55
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.00
Resistance 3 (R3) 2.01 1.96 1.97
Resistance 2 (R2) 1.96 1.92 1.96 1.97
Resistance 1 (R1) 1.91 1.90 1.88 1.90 1.96
Pivot Point 1.86 1.86 1.85 1.86 1.86
Support 1 (S1) 1.81 1.83 1.79 1.80 1.74
Support 2 (S2) 1.76 1.80 1.76 1.73
Support 3 (S3) 1.71 1.76 1.73
Support 4 (S4) 1.70